Dirk Jäger

Title: The Innovative Contributions of Dirk Jäger

Introduction

Dirk Jäger is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of immunotherapy, particularly in the development of antibodies for treating viral infections and tumors. With a total of two patents to his name, Jäger's work is at the forefront of medical innovation.

Latest Patents

One of Jäger's latest patents is focused on a topical application for an anti-HSV antibody. This invention describes an anti-HSV antibody or an antigen-binding fragment for use in treating acute infections caused by HSV-1 or HSV-2. The patent outlines the administration of this antibody topically, along with a pharmaceutical composition that includes an effective amount of the antibody and at least one pharmaceutically acceptable excipient. Another notable patent is for a monoclonal human tumor-specific antibody. This patent provides novel human tumor-specific antibodies that recognize the tumor-associated antigen NY-ESO-1, along with pharmaceutical compositions for treating tumors.

Career Highlights

Throughout his career, Dirk Jäger has worked with notable organizations such as Heiselberg Immunotherapeutics GmbH and the University of Zurich. His work in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Jäger has collaborated with several professionals in his field, including Michaela Arndt and Jürgen Krauss. These collaborations have further enriched his research and development efforts.

Conclusion

Dirk Jäger's contributions to the field of immunotherapy through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in the treatment of viral infections and tumors.